3D Bioprinting, also known as additive manufacturing, is used to make three dimensional solid objects from a digital file which is achieved by using additive processes.
3D Bioprinting technology developed from prototyping in various applications for development of actual usable parts and products. The 3D bioprinting market facilitates opportunities for prostheses, dental implants, hearing aids, contact lenses, hip implants, custom made knees etc. that are customized and personalized according to the individual, one of the advances of 3D printing is known as bioprinting or the ability to print living tissue. The 3D printer uses “bio-ink,” a blend of living cells, the bioprinter can create a structure from these cells, layer by layer, to form human tissue. With the help of 3D bioprinting physicians can use patient-specific data to capture, modify and apply various physical solutions of all shapes and sizes to the patient. Without such applications and technology, personalized treatment would be difficult, as patients would be unable to access the unique parts that can be rapidly and simply manufactured using bioprinting. It also serves to reduce surgery cost, time, trauma and the healing period which is beneficial for both patient and surgeon.
3D Bioprinting Market: Drivers and Restraints
Presently, global 3D printing in the healthcare market is driven by the advancement in technology, an increase in the percentage of the aging population, improvement in the healthcare infrastructure, and an increase in the investment in research and development sector.
Technological advances in this dynamic industry are ever ongoing applications of additive manufacturing in healthcare are expanding. However, lack of skilled professionals act as a major barrier for the bioprinting healthcare market.
3D Bioprinting Market: Segmentation
The global 3D bioprinting market is segmented into the following types:
- Electron beam melting
- Laser beam melting
- Stereo lithography
- Digital light processing
- Two-photon polymerization
- Droplet disposition
- Inkjet printing
- Fused disposition modeling
- Multi-phase jet solidification
3D Bioprinting Market: Overview
With rapid technological advancement and increase in the investment in R&D sector, the global 3D bioprinting market is expected to have a healthy growth rate in the forecast period (2015-2025).
The 3D bioprinting market is expected to witness significant growth, owing to intervention of government for improving healthcare infrastructure and increasing investment in the R&D sector. In addition, healthcare professionals increasingly explore 3D bioprinting because it reduces the risks associated with anesthesia during long surgeries and improves healthcare.
3D Bioprinting Market: Region-wise Outlook
The global 3D bioprinting market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
North America is the leading market for 3D bioprinting whereas Europe is expected to capture the large market shares followed by Asia Pacific region where the market is expected to grow due to rapid technological innovations, huge investment in research and development in these regions, a large consumer base, and high disposable income.
3D Bioprinting Market: Key Players
Some of the key participating global players in 3D bioprinting global market are Stratasys Ltd., 3D Systems, Inc., Materialise NV, Organovo Holdings Inc., SOLS Systems, Youbionic, The Pexion Group, Oceanz 3D printing & Additive Manufacturing, and others.